JENNIFER CANFIELD: Open Payments
NPI 1467481119 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 70 payments from 22 companies in 2025. Trend: 2023 $1,750 · 2024 $1,170 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $278 |
| Novo Nordisk Inc | 10 | $177 |
| PFIZER INC. | 10 | $173 |
| Abbott Laboratories | 3 | $91 |
| Esperion Therapeutics, Inc. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Exact Sciences Corporation | 3 | $61 |
| Astellas Pharma US Inc | 3 | $55 |
| Amgen Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $50 |
Products named: ELIQUIS, UBRELVY, VRAYLAR, NEXLETOL, LEQVIO, The Cologuard Plus Collection Kit, Ozempic, Veozah.
Industry payments across FL — which companies pay providers there.
